According to a recent report, it has been revealed that there has been the discovery of a new drug therapy that can be used for the treatment of sickle cell anaemia in young children. The name of the drug is hydroxicarbamide and it has proved to be able to reduce the complications together with other pain related disorders in a research that was conducted on as many as 200 babies.
The study took a period of two years to complete the study and there were comparisons conducted of the inactive placebos in the babies with this new drug and it was found that it proved to be beneficial. Anaemia is a hereditary disease and it occurs when the red blood cells of the body tend to stick to the blood vessels.
The ailment tends to cause a lot of pain and discomfort together with a number of other complications. The drug, hydroxicarbamide has already been used as a licensed drug in the UK for the treatment of this ailment. It has been used because the therapy seems to have acted fairly well for the disease. According to this well organized study it has been revealed that there are going to be good results of the therapy and that it is totally safe for use.
No comments:
Post a Comment